SA pharmaceutical manufacturer Cipla Medpro, a wholly owned subsidiary of Indian generic giant Cipla, has acquired a 30% stake in local digital health company Brandmed for R65m, it announced on Tuesday. The deal offers Cipla Medpro, which is SA’s third-largest pharmaceutical company operating in the private sector, an opportunity to boost sales of its products for treating noncommunicable diseases, as Brandmed’s system aims to improve patient adherence to their pill-taking schedules. Brandmed has developed a digital system for diagnosing and managing noncommunicable diseases such as hypertension, diabetes, and asthma. It links a Bluetooth-enabled device, such as a blood pressure cuff, to a smartphone app, which delivers regular reports to the patient’s doctor to help manage the patient’s disease. It also triggers the provision of emergency services, if the captured data signals an imminent crisis, such as a stroke. Cipla Medpro CEO Paul Miller said the company will make further i...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.